|
|
Molecular and Cellular Basis of Neurodevelopmental Disorders |
| 1 R01 MH113948-01A1 |
POWELL, CRAIG M |
NIMH |
2020 |
|
|
Characterization of the role of Fmr1 in oxytocin neuronal subtypes |
| 1 R01 MH117127-01A1 |
DÖLEN, GÜL |
NIMH |
2020 |
|
|
Metabolic changes underlying 16p11.2 deletion syndrome |
| 1 R01 MH119173-01A1 |
SIVE, HAZEL L |
NIMH |
2020 |
|
|
Cerebellum and cerebellar-regulated circuit contribution to Fragile X Syndrome |
| 1 R01 MH120069-01A1 |
TSAI, PETER T |
NIMH |
2020 |
|
|
Chronic Axon Hypofunction in Maternal Immune Activation Models of Neurodevelopmental Disorders |
| 1 R01 MH121075-01A1 |
HUGUENARD, JOHN R |
NIMH |
2020 |
|
|
Genetic Strategies for Neurodevelopmental Research |
| 1 R01 MH121447-01 |
AMARAL, DAVID G |
NIMH |
2020 |
|
|
High-throughput modeling of autism risk genes using zebrafish |
| 1 R01 MH121601-01A1 |
PROBER, DAVID AARON |
NIMH |
2020 |
|
|
Blood-brain barrier monoamine metabolism regulation of social behavior |
| 1 R01 MH121761-01A1 |
DANEMAN, RICHARD |
NIMH |
2020 |
|
|
Mutant Shank3 macaque monkeys for neurobiological studies of ASD |
| 1 R01 MH121802-01 |
DESIMONE, ROBERT |
NIMH |
2020 |
|
|
Prenatal striatal morphogenesis: maternal and placental contributions and behavioral consequences |
| 1 R01 MH122485-01 |
STEVENS, HANNA E |
NIMH |
2020 |
